Table 1.
Gender | Total population of newborns exposed to SARS-CoV-2 N. of patients (N, %) |
SARS-CoV-2 at birth (N, %) |
SARS-CoV-2 during pregnancy (N, %) |
Newborns non exposed to SARS-CoV-2 (N, %) |
---|---|---|---|---|
Female Male |
62 (44,6%) 77 (55,4%) |
46 (40,7%) 67 (59,3%) |
15 (57,7%) 11 (42,3%) |
60 (43,1%) 79 (56,9%) |
Gestational age at birth (weeks) | ||||
M ± SD | 38.4 ± 1.9 | 38.3 ± 2.02 | 38.7 ± 1.3 | 38,9 ± 1.3 |
Mdn | 39 | 39 | 39.05 | 39.2 |
Mo | 39 | 39 | 38.3 | 38.6 |
Weight at birth (grams) | ||||
M ± SD | 3142,8 ± 549,4 | 3129,5 ± 585,6 | 3200,7 ± 354, 4 | 3230 ± 336 |
Mdn | 3200 | 3200 | 3187,5 | 3210 |
Mo | 3400 | 3400 | 2940 | 3010 |
Prematurity rate | ||||
Total population | 20 (14,3%) | 16 (80%) | 4 (20%) | 18 (12,9%) |
GA 34 – 37 W | 14 | 4 | ||
GA 29–33 W | 2 |
Mdn median, M mean, Mo mode, SD standard deviation, GA gestational age, N number, W weeks